Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients

International Journal of Biological Markers

Volumn 24, Issue 4, 2009, Pages 253-257

  Casadio, Valentina ^a   Bravaccini, Sara ^a   Gunelli, Roberta ^b   Nanni, Oriana ^a   Zoli, Wainer ^a   Amadori, Dino ^a   Calistri, Daniele ^a   Silvestrini, Rosella ^a  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

Bladder cancer; Early diagnosis; Symptomatic patients; Urine telomerase activity

Indexed keywords

TELOMERASE;

AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENZYME ACTIVITY; ENZYMURIA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; URINE CYTOLOGY;

EID: 76649084901     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2009.848     Document Type: Article

References (23)

1. American College of Surgeons. Commission on Cancer National Cancer Database. Available at URL: http://www.facs.org/cancer/ncdb/index.html. Accessed June 23, 2008.
2. Messing EM, Young TB, Hunt VB, et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology 1995; 45: 387-96.
3. Messing EM, Madeb R, Young T, et al. Long-term outcome of hematuria home screening for bladder cancer in men. Cancer 2006; 107: 2173-9.
4. Liou LS. Urothelial cancer biomarkers for detection and surveillance. Urology 2006; 67: 25-33.
5. Hoque MO , Begum S, Topaloglu O, et al. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst 2006; 98: 996-1004.
6. Zhao J, He D, He H, Li L, Zhang LL, Wang XJ. Primary application study in early diagnosis of bladder cancer by survivin molecular beacons. Urology 2007; 70: 60-4.
7. Chang HW, Tsui KH, Shen LC, Huang HW, Wang SN, Chang PL. Urinary cell-free DNA as a potential tumor marker for bladder cancer Int J Biol Markers 2007; 22: 287-94.
8. Zancan M, Franceschini R, Mimmo C, et al. Free DNA in urine: a new marker for bladder cancer? Preliminary data. Int J Biol Markers 2005; 20: 134-6.
9. Volpe A, Racioppi M, D'Agostino D, et al. Bladder tumor markers: a review of the literature. Int J Biol Markers 2008; 23: 249-61.
10. Sanchini MA, Bravaccini S, Medri L, et al. Urine telomerase, an important marker in the diagnosis of bladder cancer. Neoplasia 2004; 6: 234-9.
11. Sanchini MA, Gunelli R, Nanni O, et al. Relevance of urine telomerase in the diagnosis of bladder cancer. JAMA 2005; 294: 2052-6.
12. Pepe MS, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001; 93: 1054-61.
13. Gluud C, Gluud LL. Evidence based diagnostics. BMJ 2005; 330: 724-6.
14. Fedriga R, Gunelli R, Nanni O, Bacci F, Amadori D, Calistri D. Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine. Neoplasia 2001; 3: 446-50.
15. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000; 163: 524-7.
16. Grossman HB, Soloway M, Messing E, et al. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA 2006; 295: 299-305.
17. Lotan Y, Svatek RS, Sagalowsky AI. Should we screen for bladder cancer in a high-risk population? A cost per lifeyear saved analysis. Cancer 2006; 107: 982-90.
18. Sozen S, Eskicorabci S, Ozen H. Urinary markers for urothelial cancer. BJU Int 2003; 92: 531-3.
19. Al-Sukhun S, Hussain M. Current understanding of the biology of advanced bladder cancer. Cancer 2003; 97: 2064-75.
20. Konety BR, Joyce GF, Wise M. Bladder and upper tract urothelial cancer. J Urol 2007; 177: 1636-45.
21. Yossepowitch O, Herr HW, Donat S. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. J Urol 2007; 177: 1277-82.
22. Bravaccini S, Sanchini MA, Granato AM, et al. Urine telomerase activity for the detection of bladder cancer in females. J Urol 2007; 178: 57-61 .
23. Sharma S, Zippe CD, Pandrangi L, Nelson D, Agarwal A. Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat. J Urol 1999; 162: 53-7.